Skip to main content
ASHI 51st Annual Meeting Main banner

Marlena Habal, MD

Assistant Professor Of Medicine
NYU Grossman School of Medicine
New York, NY

Marlena Habal, MD, is Assistant Professor of Medicine at New York University Grossman School of Medicine. She received her Medical Degree from the University of Toronto and trained in heart failure and cardiac transplantation at Columbia University Medical Center in New York followed by a research fellowship at the Columbia Center for Translational Immunology focusing on the role of T cells in cardiac allograft vasculopathy. She joined the faculty at Columbia University in 2018 until 2022 when she moved to New York University to develop a translational research program focusing on humoral alloimmunity in thoracic organ transplantation. She has a strong interest in pretransplant allosensitization having developed therapeutic desensitization strategies that are based on mechanistic rationale. Her laboratory is studying alloreactive B cells, investigating ways in which they escape under contemporary immunosuppression to drive persistent humoral responses. She is the Principal Investigator for a multicenter clinical trial of belatacept with gradual calcineurin inhibitor (CNI)-withdrawal in heart transplantation with the goal of better mitigating pathogenic humoral alloimmunity and minimizing CNI-induced nephrotoxicity. She leads a rapidly growing desensitization program at NYU that is committed to the management of the immunologically complex patient before and after transplant.

Presentation(s):